Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-105450
Filing Date
2023-10-02
Accepted
2023-09-29 17:57:16
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2327224d1_sc14d9c.htm SC14D9C 18437
2 EXHIBIT 99.1 tm2327224d1_ex99-1.htm EX-99.1 12327
  Complete submission text file 0001104659-23-105450.txt   32493
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Filed by) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Subject) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87033 | Film No.: 231297029
SIC: 2834 Pharmaceutical Preparations